Hematology NewsFirst-line bortezomib prolongs survival in MCLOctober 25, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology Times‘Mechanoprimed’ MSCs aid hematopoietic recoveryOctober 25, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantation
Hematology TimesCombo can prolong overall survival in MCLOctober 25, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasB Cell Lymphoma
Hematology NewsOlder age predicts mortality after alloHCT in NHL, but not relapseOctober 24, 2018Aggressive LymphomasCellular TherapyLymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology NewsWhen to choose stem cell transplant in PTCLOctober 24, 2018T Cell LymphomasLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology TimesAge limits restrict AYA participation in relevant trialsOctober 22, 2018Lymphoma & Plasma Cell DisordersPediatrics
Hematology NewsStudy challenges LVEF assessment before DLBCL treatmentOctober 19, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology TimesStudy supports sequencing in kids with cancerOctober 19, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Hematology NewsIbrutinib discontinuation harms survival in CLLOctober 18, 2018CLLMantle Cell LymphomaIndolent LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology TimesBTK inhibitor shows early promise for WMOctober 18, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimessNDA gets priority review for CLL/SLLOctober 18, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesUnderstanding the role of HSCT in PTCLOctober 17, 2018Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin Lymphoma
Hematology TimesFDA issues draft guidance on MRDOctober 16, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLCMLNon-Hodgkin Lymphoma
Hematology NewsEntospletinib falls short in relapsed/refractory DLBCLOctober 11, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular LymphomaB Cell Lymphoma
Hematology NewsUpdated ThroLy system predicts need for thromboprophylaxisOctober 11, 2018ThrombosisLymphoma & Plasma Cell DisordersAggressive LymphomasIndolent Lymphoma
